Yunsen Zhang , Chenyu Lin , Zhongmin Zhao , Zheng Wu , Hao Zhong , Nannan Wang , Tianshu Lu , Huanle Xu , Defang Ouyang
{"title":"FormulationMM: A universal computer-driven drug formulation platform","authors":"Yunsen Zhang , Chenyu Lin , Zhongmin Zhao , Zheng Wu , Hao Zhong , Nannan Wang , Tianshu Lu , Huanle Xu , Defang Ouyang","doi":"10.1016/j.jconrel.2025.114237","DOIUrl":null,"url":null,"abstract":"<div><div>Classical computer-aided drug design answers “Will this ligand bind?”, whereas computer-driven drug formulation answers the downstream but equally critical question “How can this drug be physically formulated and delivered?”, thereby bridging the long-standing gap between molecular modeling and drug formulation science through physics-based and fully automated multiscale simulation. To build this bridge, we introduce FormulationMM, an innovative platform utilizing real-world driven molecular modeling to explore drug formulation mechanisms. FormulationMM features a pharmaceutical formulation algorithm, an integrated excipient database, and robust modeling protocols, ensuring a streamlined workflow for the generation, simulation, and analysis of drug formulation. It automatically generates force field parameters for drug molecules and excipients, supporting six formulation types: cyclodextrin-drug inclusion, micelles, liposomes, solid dispersions, self-assembling drug nanoparticles, and transmembrane drug delivery systems. Our results closely match experimental findings and demonstrate high predictive accuracy and reliability. FormulationMM, accessible through a continuously updated website (<span><span>https://formulationmm.computpharm.org</span><svg><path></path></svg></span>), offers a practical platform to support drug formulation research and development, with the potential to advance the growing field of computer-driven drug formulation.</div></div>","PeriodicalId":15450,"journal":{"name":"Journal of Controlled Release","volume":"387 ","pages":"Article 114237"},"PeriodicalIF":11.5000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Controlled Release","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168365925008491","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Classical computer-aided drug design answers “Will this ligand bind?”, whereas computer-driven drug formulation answers the downstream but equally critical question “How can this drug be physically formulated and delivered?”, thereby bridging the long-standing gap between molecular modeling and drug formulation science through physics-based and fully automated multiscale simulation. To build this bridge, we introduce FormulationMM, an innovative platform utilizing real-world driven molecular modeling to explore drug formulation mechanisms. FormulationMM features a pharmaceutical formulation algorithm, an integrated excipient database, and robust modeling protocols, ensuring a streamlined workflow for the generation, simulation, and analysis of drug formulation. It automatically generates force field parameters for drug molecules and excipients, supporting six formulation types: cyclodextrin-drug inclusion, micelles, liposomes, solid dispersions, self-assembling drug nanoparticles, and transmembrane drug delivery systems. Our results closely match experimental findings and demonstrate high predictive accuracy and reliability. FormulationMM, accessible through a continuously updated website (https://formulationmm.computpharm.org), offers a practical platform to support drug formulation research and development, with the potential to advance the growing field of computer-driven drug formulation.
期刊介绍:
The Journal of Controlled Release (JCR) proudly serves as the Official Journal of the Controlled Release Society and the Japan Society of Drug Delivery System.
Dedicated to the broad field of delivery science and technology, JCR publishes high-quality research articles covering drug delivery systems and all facets of formulations. This includes the physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries.
Priority is given to manuscripts that contribute to the fundamental understanding of principles or demonstrate the advantages of novel technologies in terms of safety and efficacy over current clinical standards. JCR strives to be a leading platform for advancements in delivery science and technology.